In Reply We appreciate the comments from Cheng and Hsu regarding our study on the clinical effectiveness of newborn screening (NBS) for spinal muscular atrophy (SMA). Their observations bring valuable perspectives that merit further discussion.
Home>>Clinical Practice Guidelines>>Concerns About Clinical Effectiveness of Newborn Screening for Spinal Muscular Atrophy—Reply
Clinical Practice Guidelines